Teva optimistic about outcome in Teva v. Sandoz (!)

Note Reuters post Teva optimistic U.S. top court to rule in favor of MS drug patent with text



Teva Pharmaceutical Industries is optimistic the U.S. Supreme Court will decide in its favor regarding patent protection for Copaxone, its multiple sclerosis treatment, Chief Executive Erez Vigodman said on Thursday.


IPBiz suspects, no matter what legal formalism is adopted, Teva will lose the case.